Company: IXHL
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001213900-25-092837
Chunk: 394

Company: Incannex Healthcare Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 1A
Chunk 394
---
 any and all capacities, to (i)
act on and sign any amendments to this report, with exhibits thereto and other documents in connection therewith, (ii) act on and sign
such certificates, instruments, agreements and other documents as may be necessary or appropriate in connection therewith, and in each
case file the same with the SEC, hereby approving, ratifying and confirming all that such agent, proxy and attorney-in-fact or any of
his substitutes may lawfully do or cause to be done by virtue thereof.

Pursuant to the requirements of the Securities
Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the registrant and in the capacities
and on the dates indicated.

    Name
     
    Position
     
    Date

    /s/ Joel Latham
     
    Chief Executive Officer, President and Director
     
    September 29, 2025
  
    Joel Latham
     
    (principal executive officer)

    /s/ Joseph Swan
     
    Chief Financial Officer
     
    September 29, 2025
  
    Joseph Swan
     
    (principal financial and accounting officer)

    /s/ Troy Valentine
     
    Director
     
    September 29, 2025
  
    Troy Valentine

    /s/ Peter Widdows
     
    Director
     
    September 29, 2025
  
    Peter Widdows

    /s/ George Anastassov
     
    Director
     
    September 29, 2025
  
    George Anastassov

    /s/ Robert Clark
     
    Director
     
    September 29, 2025
  
    Robert Clark

98

2233

0001873875
false
FY

    0001873875

    2024-07-01
    2025-06-30

    0001873875

    2024-12-31

    0001873875

    2025-09-28

    0001873875

    2025-06-30

    0001873875

    2024-06-30

    0001873875

    2023-07-01
    2024-06-30

    0001873875
    
      us-gaap:CommonStockMember